Research focus will be on the synthesis and evaluation of radiopharmaceuticals based on receptor-targeted small peptides and synthetic polymers for diagnostic and therapeutic applications in cancer. The postdoc will also be involved with in vitro and in vivo radiometabolite identification as well as other aspects in the biological evaluation of the synthesized diagnostic and therapeutic agents. Ph.D. Pharmaceutical Sciences or related Science fields. Experience with LC/MS a plus.